HP
FSTX

Hikari Power’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Hikari Power’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-32,818
Closed -$207K – 114
2019
Q4 		$207K Sell
32,818
-7,411
-18% -$94.2K 0.02% 98
2019
Q3 		$554K Buy
40,229
+24,895
+162% +$410K 0.06% 74
2019
Q2 		$226K Buy
15,334
+1,950
+15% +$52.2K 0.02% 90
2019
Q1 		$562K Hold
13,384
– – 0.06% 67
2018
Q4 		$556K Buy
13,384
+10,550
+372% +$474K 0.06% 69
2018
Q3 		$137K Buy
+2,834
New +$142K 0.01% 127

Other funds holding FSTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TA
Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
ED
Exane Derivatives Paris, France $174M AUM 7.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $1.14B AUM 48.66% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Hikari Power's FSTX Position: Q1 2020 in Review

Hikari Power sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2020, closing a stake of 32,818 shares — an estimated $207K sold.

Hikari Power first reported a position in FSTX in Q3 2018 and held it in 6 quarters. The position peaked at $562K in Q1 2019. 28 funds tracked by Wall St. Rank hold FSTX as of Q1 2020.

  • Hikari Power reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Hikari Power sold 32,818 F-star Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $207K.
  • Hikari Power first reported a position in F-star Therapeutics, Inc. Common Stock in Q3 2018 and held it in 6 quarters.
  • Hikari Power's F-star Therapeutics, Inc. Common Stock position peaked at $562K in Q1 2019.
  • 28 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Hikari Power's 13F filing for Q1 2020, filed 23 Apr 2020.